Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COGT

Cogent Biosciences Inc

May 29 • 01:12PM ET

35.21

-0.17 -0.47 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KYMR BMRN RYTM APGE KRYS NUVL VKTX AXSM MDGL NBIX

| Held by: VTI VB IWM XBI VBR VXF IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.52	Insider Own	13.94%	Shs Outstand	170.77M	Perf Week	8.09%
Market Cap	6.02B	Forward P/E	-	EPS next Y	-0.78	Insider Trans	-31.23%	Shs Float	147.08M	Perf Month	-1.83%
Enterprise Value	5.45B	PEG	-	EPS next Q	-0.55	Inst Own	97.07%	Short Float	7.59%	Perf Quarter	-9.36%
Income	-354.30M	P/S	-	EPS this Y	-3.86%	Inst Trans	7.77%	Short Ratio	5.41	Perf Half Y	-11.34%
Sales	0.00M	P/B	11.08	EPS next Y	65.02%	ROA	-59.71%	Short Interest	11.16M	Perf YTD	-0.86%
Book/sh	3.18	P/C	6.94	EPS next 5Y	-	ROE	-85.72%	52W High	43.73 -19.47%	Perf Year	539.09%
Cash/sh	5.07	P/FCF	-	EPS past 3/5Y	-2.22% 30.89%	ROIC	-41.93%	52W Low	5.03 600.08%	Perf 3Y	213.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.85% 4.07%	Perf 5Y	306.63%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	0.01%	Oper. Margin	-	ATR (14)	1.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.10	Recom	1.31
Dividend Gr. 3/5Y	- -	Current Ratio	15.14	EPS Q/Q	5.50%	SMA20	2.76%	Beta	0.34	Target Price	54.25
Payout	-	Debt/Eq	0.39	Sales Q/Q	-	SMA50	-0.51%	Rel Volume	0.67	Prev Close	35.38
Employees	258	LT Debt/Eq	0.39	Earnings	May 05 BMO	SMA200	18.83%	Avg Volume	2.06M	Price	35.21
IPO	Mar 29, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.49% -	Trades		Volume	814,021	Change	-0.47%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)